An autoimmune hypothesis for the etiology of Meniere's disease has been proposed. In this study, we focused on gangliosides as potential antigens for autoantibodies in Meniere's disease patients. In an attempt to investigate ganglioside antigens which respond to the serum of patients with Meniere's disease, we analyzed gangliosides of human acoustic neurinomas, and used them as antigens to broadly explore gangliosides that react to serum. All the acoustic neurinoma samples used in the present study showed a similar ganglioside profile on TLC (thin-layer chromatography). For the microscale ganglioside analysis, a newly developed TLC blotting/secondary ion mass spectrometry (SIMS) system together with TLC immunostaining method was employed. Most of the ganglioside bands could be analyzed, and they were identified as GM3, GM2, SPG, GM1a, GD3, S-i (sialyl-i ganglioside) and GD1a. GD1a was the predominant ganglioside and many neolactoseries gangliosides were recognized by immunological analysis. Next, the immune reactivity of serum samples, from patients with Meniere's disease, with the acoustic neurinoma gangliosides was studied by TLC immunostaining. The result showed that five of 11 patients with Meniere's disease and one of eight normal subjects reacted with a specific band, which was identified as S-i by the TLC blotting/SIMS system. The findings of the present study indicate that S-i ganglioside is an autoantigen and possibly involved in the pathogenesis of Meniere's disease. ß 2000 Elsevier Science B.V. All rights reserved. 0925-4439 / 00 / $^see front matter ß 2000 Elsevier Science B.V. All rights reserved. PII: S 0 9 2 5 -4 4 3 9 ( 0 0 ) 0 0 0 1 2 -0
Introduction
Meniere's disease is an inner ear disease characterized by episodic attacks of vertigo, £uctuating cochlear hearing loss, tinnitus, and a feeling of fullness in the a¡ected ear. The condition underlying Meniere's disease has been found to be endolymphatic hydrops [2] . However, the causes of endolymphatic hydrops remain unknown, although various hypotheses have been proposed. Recently, the autoimmune hypothesis has been proposed and actively discussed [3, 4] . This hypothesis is based on clinical ¢ndings of increases in blood immune complex levels [5, 6] , the e¤cacy of steroids for hearing loss [3, 5, 7, 8] , and the high concentration of IgG in endolymph [9] , as well as the basic ¢ndings that endolymphatic hydrops are observed in animals immunized with such antigens as inner ear tissues [10, 11] or collagen [12, 13] , and that immune reaction in the endolymphatic sac causes £uctuating hearing loss [14] . Gangliosides are acidic glycosphingolipids with sialic acid, and are particularly abundant in the vertebral nervous system. We have elucidated the involvement of glycosphingolipids in the onset of Guillain^Barrë syndrome, an autoimmune neurological disease [15] . The inner ear has peripheral sensory cells, and is thought to include large amounts of gangliosides. We planned to examine whether autoantibodies against ganglioside in the inner ear play a role in the etiology of Meniere's disease. However, it is extremely di¤cult to collect samples of human inner ear tissues, and amounts are extremely small even if samples can be collected. Accordingly, we attempted to take advantage of the neoplastic growth of the 8th cranial nerve (vestibular nerve) in acoustic neurinoma [16] . Neurinoma is a benign tumor which originates from Schwann cells in the peripheral nerve. Despite the nerve origin of neurinomas, very few studies have been made on gangliosides in them. We analyzed gangliosides of human acoustic neurinomas, and used them as antigens to broadly explore gangliosides that react to the sera of patients with Meniere's disease. We used TLC blotting/SIMS [17, 18] , as well as a combination of this technique and TLC immunostaining. The purpose of this study is to isolate and characterize the gangliosides of human acoustic neurinoma, and to examine the ganglioside antigens that respond to sera from patients with Meniere's disease.
Materials and methods

Materials
Acoustic neurinoma samples were obtained from seven cases. Surgery was performed at the Department of Otolaryngology, Tokyo Medical and Dental University. All cases were diagnosed histopathologically as neurinoma (mixed type Antoni A+B).
Puri¢cation of gangliosides
Acoustic neurinoma samples were suspended in a mixture of chloroform:methanol (2:1, by vol). Lipids were extracted by stirring the mixture, and then ¢ltering it through a glass wool-packed Pasteur pipette and evaporating the ¢ltrate to dryness. Total lipid extracted from the tumor was applied to a DEAE Sephadex column. Neutral glycolipids and most of the phospholipids were eluted with a mixture of chloroform:methanol:water (30:60:8, v/v). Gangliosides were eluted with a mixture of chloroform: methanol:0.8 N CH 3 COONa (30:60:8, v/v). The ganglioside-containing fraction was evaporated to dryness under reduced pressure in a rotary evaporator, and then dissolved in distilled water. The ganglioside solution was applied to a Sep-Pak C18 (Waters Division of Millipore, Milford, MA, USA). Gangliosides were eluted with methanol after washing the column with 20^30 ml of water. The obtained ganglioside fraction was used for further analysis by TLC and TLC blotting/SIMS analysis, and also for TLC immunostaining.
Thin-layer chromatography (TLC)
Gangliosides were separated by TLC on precoated silica gel Merck 60 plates (HPTLC plates purchased from E. Merck, Darmstadt, Germany). The developing solvent system was a mixture of chloroform:methanol:0.2% aqueous CaCl 2 (55:45:10, v/v). Gangliosides were visualized by spraying the plate with resorcinol^HCl reagent. Standard gangliosides GM1a, GD1a, GD1b and GT1b were prepared from bovine brains. Standard gangliosides GM3, SPG, S-i and S-I were prepared from human placenta [19] . Standard glycosphingolipids SGPG and SGLPG were gifts from Dr. T. Ariga (Virginia Commonwealth University, VA, USA) [20] .
TLC blotting
TLC blotting was performed as described elsewhere [17, 18] . Brie£y, gangliosides were applied to an HPTLC plate and then developed. After development, primuline reagent was sprayed over the plate. The gangliosides on the plate were viewed under ultraviolet light at 365 nm. While the plate was illuminated, each ganglioside area was marked with a color drawing pencil. The HPTLC plate was then immersed for 20 s in a solvent composed of isopropanol:0.2% aqueous CaCl 2 :methanol (40:20:7, v/v). It was then placed on a glass plate, after which a PVDF membrane sheet (Clear Blott Membrane-P, ATTO Co. Ltd., Tokyo, Japan) and then a glass micro¢ber ¢lter sheet (GF/A, Whatman International Ltd., Maidstone, UK) were placed over the glass plate. The assemblage was pressed for 15 s with a 180³C iron. The PVDF membrane was then separated from the plate and dried. This method has been referred to as the`Far-Eastern blot' [18] .
Mass spectrometric analysis of gangliosides
The ganglioside areas on the PVDF membrane were subjected to SIMS. Each marked ganglioside area was excised and trimmed to form a circle 2 mm in diameter that ¢t the probe tip of the MS equipment. One microliter of triethanolamine was placed on the PVDF membrane. Negative SIMS spectra were obtained with a Finnigan TSQ70 mass spectrometer. The ganglioside on the membrane was bombarded with a C s beam at 20 kV. The ion multiplier was 1.5 kV and the conversion diode was 20 kV.
TLC immunostaining and antibodies
TLC immunostaining was performed as described elsewhere [21] . The SPS-20 monoclonal antibody spe-ci¢c for SPG and S-i was a gift from Dr. Y. Kushi (Tokyo Medical and Dental University) [22] . MAb speci¢c for GM1a was a gift from Dr. T. Tai (Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan). MAb speci¢c for GD3 was a gift from Dr. J. Portoukalian (INSERM, Lyon, France). The monoclonal antibody H11, directed to the Gal L 1-4GlcNAc L 1-3Gal of glycosphingolipids, was prepared as described elsewhere [23] . These MAbs were used as ¢rst antibodies. Horseradish peroxidase-conjugated goat anti-mouse IgM antibody, for use as a second antibody, was purchased from Cappel Lab (Westchester PA; 1:1000 dilution). A Konica Immunostain Kit (Konica Co., Inc., Tokyo, Japan) reagent was used as a staining reagent.
Sialidase assay on HPTLC plate
This assay was performed as reported elsewhere [24] . Clostridium perfringens sialidase (type VI) was purchased from Sigma (St. Louis, MO, USA). Gangliosides obtained from human acoustic neurinoma were developed on an HPTLC plate, and the entire plate was incubated with 50 mUnits of C. perfringens sialidase/ml of 0.1 M acetate bu¡er (pH 5.5) at 37³C for 2 h. After incubation, the plate was washed with phosphate-bu¡ered saline (PBS), and the amount of nLc 4 Cer present was determined by immunostaining with the H11 monoclonal antibody.
Detection of serum antibodies to gangliosides
Sera from 11 patients with Meniere's disease were used in this study. All patients met the diagnostic criteria of the Ministry of Health and Welfare of Japan (1974) . Sera from eight individuals without any hearing-related complaints were used as normal controls.
The serum samples were diluted with 1% BSA containing PBS at 1:25, and mounted on HPTLC plates on which gangliosides from acoustic neurinomas were developed. The plates were incubated at 4³C overnight and were then washed with PBS. Peroxidase-conjugated anti-human Q-chain and W-chain-spe-ci¢c antibody (Tago, Burlingame, CA, USA; 1:1000 dilution with 1% BSA containing PBS) was overlaid on the plates, and the plates were incubated at room temperature for 2 h. After washing the plates with PBS, staining was performed using a Konica Immunostain Kit.
SGPG and SGLPG in human acoustic neurinomas
Serum with high antibody titer against SGPG and SGLPG was gift from Dr. T. Ariga (Virginia Commonwealth University, Virginia, USA). TLC immunostaining with serum antibody was performed as described above. Serum samples were diluted at 1:1000.
Results and discussion
Structural analysis of gangliosides in human acoustic neurinomas
TLC pro¢les of gangliosides from human acoustic neurinoma samples are shown in Fig. 1 . Similar patterns were obtained in the TLC chromatograms of gangliosides extracted from seven subjects.
The ganglioside fraction of sample No. 7 in Fig. 1 was subjected to TLC blotting and then used for SIMS analysis. Seven bands were visualized with ultraviolet light after being sprayed with primuline reagent. The characteristic SIMS spectra of gangliosides from human acoustic neurinomas are shown in Fig. 2 . The SIMS spectrum clearly showed that band 1 was GM3 ganglioside with C24:0 and C24:1 fatty acids and a d18:1 long chain base in its ceramide moiety. The spectrum of band 2 indicated that the ganglioside was GM2 with the same fatty acid constituents as GM3. The spectra of bands 3 and 4 revealed the same major peals at m/z 1626 and 1628. The fragmentation pro¢le of band 3 clearly indicated that the ganglioside has a NeuAc-Hex-HexNAc-Hex-Hex-Cer structure corresponding to SPG with the C24:0 and C24:1 fatty acids. While, the SIMS spectrum of band 4 showed the appearance of peaks at m/z 1464 and 1466 corresponding to GM2 fragment and GM3 fragment peak at m/z 1263, in addition to the fragments in band 3 spectrum. This fragmentation pro¢le suggested that band 4 is GM1a with the C24:0 and C24:1 fatty acids as interpreted in Fig. 2 , band 4. Band 3 was stained by anti-SPG MAb (SPS-20), and band 4 was stained by anti-GM1a MAb. Band 3 was thus identi¢ed as SPG, and band 4 as GM1a. The SIMS spectrum in Fig. 2 showed that band 5 contained two components, one corresponding to GM1 and the other to Neu-Ac(Hex) 4 (HexNAc) 1 Cer. The latter ganglioside appears to be a previously unidenti¢ed component. The ganglioside with a deprotonated molecule (1626, 1628) appeared to be GM1b with C24:0 or C24:1 fatty acid in the ceramide moiety, since its mobility was a little less than that of standard GM1a and the band was not immunostained with Fig. 1 . Left upper part: Gangliosides from standard BBG and acoustic neurinoma (AN) were separated on an HPTLC plate. Bands were visualized by spraying the plate with resorcinol reagent. Arrows show the number of ganglioside bands visualized by ultraviolet light after being sprayed with primuline reagent, and correspond to those of the SIMS spectrum, respectively. SIMS spectra of (1) band 1, (2) band 2, (3) band 3, (4) band 4, (5) band 5, (6) band 6, and (7) band 7. The interpretation of fragment ions is shown.
MAb against GM1a (Fig. 3) . The SIMS spectrum suggested that band 6 was a mixture of S-i with the C24:0 and C24:1 fatty acid and GD3 with the C24:0 fatty acid. The peaks at m/z 1993 and 1991 correspond to the deprotonated ion of S-I, and their fragment peaks are interpreted in the band 6 spectrum in Fig. 2 . The peak at m/z 1554 in band 6 spectrum corresponds to the deprotonated ion of GD3 and appearance of the peak at m/z 1263 corresponding to GM3 fragment ion supports the presence of GD3 ganglioside in band 6. The MAb against GD3 was used for TLC immunostaining, and it was recon¢rmed that band 6 contained GD3 (Fig. 3 ). Band 7 corresponded to GD1a with C24:0 and C24:1 fatty acid as the major component of the ceramide moiety. GD1a was the most abundant ganglioside in all the samples (Fig. 1 ). Band 7 was the most abundant ganglioside in all the samples (Fig.  1) . The SIMS spectrum of band 7 shows a typical fragment pro¢le of GD1a. Peaks at m/z 1919 and 1917 show the deprotonated ion of GD1a with the C24:0 and C24:1 fatty acids in the ceramide moieties. All fragment ions required for GD1a are interpreted in the spectrum of band 7. The results are presented in Fig. 4 . Seven gangliosides, GM3, GM2, SPG, GM1a, GD3, S-i and GD1a, were iden-ti¢ed in human acoustic neurinomas. The presence of GM1b was also suggested. In these gangliosides, C24:0 or C24:1 fatty acid was a major component rather than C18:0, which is a major fatty acid of gangliosides in the central nervous system. The ganglioside composition of the peripheral nerve di¡ers from that in the central nervous system [25] . Since human acoustic neurinoma is a peripheral nerve tumor, we used neuraminidase treatment to examine the di¡erences between ganglioside species. The results are shown in Fig. 5 . On incubation with Fig. 3 . Immunostaining of human acoustic neurinoma with monoclonal antibody speci¢c for GM1a, SPG and GD3. Gangliosides from acoustic neurinoma (AN) and standards (BBG and SPG) were separated on an HPTLC plate. 1: Bands were visualized by spraying the plate with resorcinol reagent. 2: Immunostaining with monoclonal antibodies speci¢c for GM1a (2A), SPG (2B) and GD3 (2C). this enzyme, many ganglioside bands corresponding to N-acetyllactosamine (Gal L 1-4GlcNAc) containing neutral glycolipids were detected by immunostaining with MAb H11. These ¢ndings indicated that there are many types of N-acetyllactosamine containing ganglioside in acoustic neurinomas. However, these N-acetyllactosamines containing gangliosides except for SPG and S-i were only detected by immunostaining. None of the bovine brain ganglioside bands developed on HPTLC plates were detected with MAb H11 after C. perfringens sialidase treatment (data not shown). These ¢ndings indicate that acoustic neurinomas contained many neolactoseries gangliosides including SPG and S-i, which were not detected in adult cerebral tissue.
The presence of SGPG and SGLPG was also con-¢rmed by TLC immunostaining (Fig. 6 ). These are also very minor components and very slightly detected by immunostaining.
The ganglioside pattern found in the present study di¡ered in some respects from that in previous reports [26, 27] . We found that neurinomas contained many types of neolactoseries gangliosides, and signif-icantly higher proportions of GD1a ganglioside. Pfei¡er et al. [26] reported that the ganglioside composition of acoustic neurinoma was GM3-rich, and also included GM4, GM2, GM1, GD3 and GD1a. Shinoura et al. [27] reported that the ganglioside patterns of neurinoma were divisible into two groups: GD1a-and GM1-rich type, and GM3-rich type. Neither study mentioned neolactoseries gangliosides.
Detection of antibodies to ganglioside antigens in patients with Meniere's disease
There have been several studies of the immunoreactivity of sera from patients with Meniere's disease. Autoantibodies mentioned in these studies include an inner ear protein antigen with a molecular weight of 68 000 [28, 29] , SGLPG [30] and type II collagen [31] . However, none of these autoantibodies has been definitely con¢rmed. It has been reported that some of Fig. 6 . TLC immunostaining of the glycosphingolipids with serum from patients with high antibody titers against SGPG and SGLPG. SGPG, SGLPG and gangliosides from acoustic neurinoma (AN) were separated on HPTLC plates. The developing solvent system was a mixture of chloroform:methanol:0.2% CaCl 2 (55:45:10, v/v). 1: Bands were visualized by spraying the plate with orcinol reagent. 2: Bands were visualized by spraying the plate with resorcinol reagent. 3: TLC immunostaining of the glycosphingolipids with serum from patients with high antibody titers against SGPG and SGLPG. the autoimmune neurological diseases are related to the gangliosides. Acute [32, 33] and chronic [34] pure motor neuropathy are often associated with the anti-GM1 antibody [32, 34] or anti-GQ1b antibody [33] , and acute [35] and chronic [36] sensory ataxic neuropathies are associated with the autoantibody against b-series gangliosides.
We examined the immunoreactivity of sera of patients with Meniere's disease using gangliosides from acoustic neurinoma as antigens. TLC immunostaining revealed that ¢ve of 11 patients with Meniere's disease and one of eight normal control subjects reacted with a speci¢c band. The positive band which exhibited reactivity on TLC immunostaining was then subjected to TLC blotting/SIMS. The one spot yielded a major peak of m/z 1993, corresponding to the mass of S-i. S-i used as the standard also exhibited reactivity to patient sera on TLC immunostaining ( Fig. 7) . Yuki et al. reported the occurrence of anti-S-i antibody in Guillain^Barrë syndrome and chronic in£ammatory demyelinating neuropathy, but the frequently is not signi¢cant when the disease control and normal control were compared [37] .
It was reported that the oligosaccharide of S-i is located on the tectorial membrane surface (e.g. Kimura's membrane), sensory epithelia (outer and inner hair cells) of Corti's organ, the stria vascularis, and Reissner's membrane, in an immunohistological examination of guinea pig cochleas stained using monoclonal antibodies [38] . In immuno-£uorescence testing for identi¢cation of serum antibodies against human inner ear tissue, patients with Meniere's disease or bilateral progressive sensorineural hearing loss frequently exhibit antibody binding (mainly IgG class) to parts of the stria vascularis and Reissner's membrane [39] . In endolymphatic hydrops, a distention of Reissner's membrane is consistently observed [2] . Detection of the antibody responding to gangliosides in patients with Meniere's disease may provide evidence supporting the autoimmune hypothesis for the etiology of Meniere's disease. Ours is the ¢rst study to report that Meniere's disease patients have antibodies against gangliosides. The results of the present study suggest that S-i ganglioside is involved in the pathogenesis of Meniere's disease.
